{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:39:03Z","timestamp":1790707143220,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Health","award":["R01 GM126181"],"award-info":[{"award-number":["R01 GM126181"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sepsis, mainly caused by bacterial infections, is the leading cause of in-patient hospitalizations. After discharge, most sepsis survivors suffer from long-term medical complications, particularly chronic skeletal muscle weakness. To investigate this medical condition in detail, we previously developed a murine severe sepsis-survival model that exhibits long-term post-sepsis skeletal muscle weakness. While mitochondrial abnormalities were present in the skeletal muscle of the sepsis surviving mice, the relationship between abnormal mitochondria and muscle weakness remained unclear. Herein, we aimed to investigate whether mitochondrial abnormalities have a causal role in chronic post-sepsis muscle weakness and could thereby serve as a therapeutic target.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Experimental polymicrobial abdominal sepsis was induced in 16-18\u00a0months old male and female mice using cecal slurry injection with subsequent antibiotic and fluid resuscitation. To evaluate the pathological roles of mitochondrial abnormalities in post-sepsis skeletal muscle weakness, we utilized a transgenic mouse strain overexpressing the mitochondria-specific antioxidant enzyme manganese superoxide dismutase (MnSOD). Following sepsis development in C57BL\/6 mice, we evaluated the effect of the mitochondria-targeting synthetic tetrapeptide SS-31 in protecting mitochondria from sepsis-induced damage and preventing skeletal muscle weakness development. In vivo and in vitro techniques were leveraged to assess muscle function at multiple timepoints throughout sepsis development and resolution. Histological and biochemical analyses including bulk mRNA sequencing were used to detect molecular changes in the muscle during and after sepsis<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our time course study revealed that post sepsis skeletal muscle weakness develops progressively after the resolution of acute sepsis and in parallel with the accumulation of mitochondrial abnormalities and changes in the mitochondria-related gene expression profile. Transgenic mice overexpressing MnSOD were protected from mitochondrial abnormalities and muscle weakness following sepsis. Further, pharmacological protection of mitochondria utilizing SS-31 during sepsis effectively prevented the later development of muscle weakness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study revealed that the accumulation of mitochondrial abnormalities is the major cause of post-sepsis skeletal muscle weakness. Pharmacological protection of mitochondria during acute sepsis is a potential clinical treatment strategy to prevent post-sepsis muscle weakness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-024-00982-w","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T22:22:56Z","timestamp":1732054976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Post-sepsis chronic muscle weakness can be prevented by pharmacological protection of mitochondria"],"prefix":"10.1186","volume":"30","author":[{"given":"Meagan S.","family":"Kingren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Keeble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson M.","family":"Galvan-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi M.","family":"Ogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Ungv\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daret K.","family":"St Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"982_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303\u201310.","journal-title":"Crit Care Med"},{"key":"982_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/187153010791936946","volume":"10","author":"LCP Azevedo","year":"2010","unstructured":"Azevedo LCP. Mitochondrial dysfunction during sepsis. Endocr Metab Immune Disord Drug Targets. 2010;10:214\u201323.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"982_CR3","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/bph.12468","volume":"171","author":"AV Birk","year":"2014","unstructured":"Birk AV, Chao WM, Bracken C, Warren JD, Szeto HH. Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol. 2014;171:2017\u201328.","journal-title":"Br J Pharmacol"},{"key":"982_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/476789","volume":"2014","author":"A Borrelli","year":"2014","unstructured":"Borrelli A, et al. The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD. BioMed Res Int. 2014;2014: 476789.","journal-title":"BioMed Res Int"},{"key":"982_CR5","volume-title":"Cancer : oxidative stress and dietary antioxidants","author":"GM Calaf","year":"2014","unstructured":"Calaf GM. Cancer\u202f: oxidative stress and dietary antioxidants. Amsterdam Boston: Elsevier; 2014."},{"key":"982_CR6","doi-asserted-by":"publisher","first-page":"S354","DOI":"10.1097\/CCM.0b013e3181b6e439","volume":"37","author":"LA Callahan","year":"2009","unstructured":"Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit Care Med. 2009;37:S354-367.","journal-title":"Crit Care Med"},{"key":"982_CR7","doi-asserted-by":"publisher","first-page":"9724","DOI":"10.1111\/jcmm.16921","volume":"25","author":"YY Cao","year":"2021","unstructured":"Cao YY, et al. Sepsis induces muscle atrophy by inhibiting proliferation and promoting apoptosis via PLK1-AKT signalling. J Cell Mol Med. 2021;25:9724\u201339.","journal-title":"J Cell Mol Med"},{"key":"982_CR8","doi-asserted-by":"publisher","first-page":"15363","DOI":"10.1073\/pnas.2002250117","volume":"117","author":"JD Chavez","year":"2020","unstructured":"Chavez JD, et al. Mitochondrial protein interaction landscape of SS-31. Proc Natl Acad Sci U S A. 2020;117:15363\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"982_CR9","unstructured":"Elixhauser A, Friedman B, Stranges E, Septicemia in U.S. Hospitals, 2009: Statistical Brief #122. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Rockville (MD), 2006)."},{"key":"982_CR10","first-page":"033","volume":"2","author":"DA Englund","year":"2021","unstructured":"Englund DA, et al. Satellite cell depletion disrupts transcriptional coordination and muscle adaptation to exercise. Funct Oxf. 2021;2:033.","journal-title":"Funct Oxf"},{"key":"982_CR11","volume-title":"The mouse in aging research","author":"K Flurkey","year":"2007","unstructured":"Flurkey K, Currer JM, Harrison DE. The mouse in aging research. American College Laboratory Animal: Burlington, MA; 2007."},{"key":"982_CR12","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.3390\/ijms12107114","volume":"12","author":"AK Holley","year":"2011","unstructured":"Holley AK, Bakthavatchalu V, Velez-Roman JM, St Clair DK. Manganese superoxide dismutase: guardian of the powerhouse. Int J Mol Sci. 2011;12:7114\u201362.","journal-title":"Int J Mol Sci"},{"key":"982_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/gerona\/glp100","volume":"64","author":"YC Jang","year":"2009","unstructured":"Jang YC, et al. Overexpression of Mn superoxide dismutase does not increase life span in mice. J Gerontol A Biol Sci Med Sci. 2009;64:1114\u201325.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"982_CR14","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1212\/01.wnl.0000239826.63523.8e","volume":"67","author":"J Khan","year":"2006","unstructured":"Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology. 2006;67:1421\u20135.","journal-title":"Neurology"},{"key":"982_CR15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1089\/ars.2021.0056","volume":"35","author":"MS Kingren","year":"2021","unstructured":"Kingren MS, Starr ME, Saito H. Divergent sepsis pathophysiology in older adults. Antioxid Redox Signal. 2021;35:1358\u201375.","journal-title":"Antioxid Redox Signal"},{"key":"982_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.855006","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Ji M, Yang J. Current understanding of long-term cognitive impairment after sepsis. Front Immunol. 2022;13: 855006.","journal-title":"Front Immunol"},{"key":"982_CR17","unstructured":"Liang, L, Moore B, Soni A. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2017: Statistical Brief #261. in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Rockville (MD), 2006)."},{"key":"982_CR18","doi-asserted-by":"publisher","first-page":"F970","DOI":"10.1152\/ajprenal.00697.2013","volume":"306","author":"S Liu","year":"2014","unstructured":"Liu S, Soong Y, Seshan SV, Szeto HH. Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis. Am J Physiol Renal Physiol. 2014;306:F970-980.","journal-title":"Am J Physiol Renal Physiol"},{"key":"982_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fcvm.2019.00167","volume":"6","author":"P Machiraju","year":"2019","unstructured":"Machiraju P, et al. SS-31 peptide reverses the mitochondrial fragmentation present in fibroblasts from patients with DCMA, a mitochondrial cardiomyopathy. Front Cardiovasc Med. 2019;6:167.","journal-title":"Front Cardiovasc Med"},{"key":"982_CR20","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/jcm10091874","volume":"10","author":"RT Mankowski","year":"2021","unstructured":"Mankowski RT, Laitano O, Clanton TL, Brakenridge SC. Pathophysiology and treatment strategies of acute myopathy and muscle wasting after sepsis. J Clin Med. 2021;10:1874.","journal-title":"J Clin Med"},{"key":"982_CR21","doi-asserted-by":"publisher","first-page":"5985209","DOI":"10.1155\/2017\/5985209","volume":"2017","author":"K Mantzarlis","year":"2017","unstructured":"Mantzarlis K, Tsolaki V, Zakynthinos E. Role of oxidative stress and mitochondrial dysfunction in sepsis and potential therapies. Oxid Med Cell Longev. 2017;2017:5985209.","journal-title":"Oxid Med Cell Longev"},{"key":"982_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/01.CCM.0000194535.82812.BA","volume":"34","author":"GS Martin","year":"2006","unstructured":"Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34:15\u201321.","journal-title":"Crit Care Med"},{"key":"982_CR23","unstructured":"McDermott KW. Most frequent principal diagnoses for inpatient stays in U.S. hospitals, 2018. HCUP statistical brief #277. Agency Healthc. Res. Qual. 2021."},{"key":"982_CR24","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1074\/jbc.RA119.012094","volume":"295","author":"W Mitchell","year":"2020","unstructured":"Mitchell W, et al. The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action. J Biol Chem. 2020;295:7452\u201369.","journal-title":"J Biol Chem"},{"key":"982_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.950646","volume":"13","author":"N Nakanishi","year":"2022","unstructured":"Nakanishi N, et al. Sepsis causes neutrophil infiltration in muscle leading to muscle atrophy and weakness in mice. Front Immunol. 2022;13: 950646.","journal-title":"Front Immunol"},{"key":"982_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5492\/wjccm.v12.i3.139","volume":"12","author":"W Nedel","year":"2023","unstructured":"Nedel W, Deutschendorf C, Portela LVC. Sepsis-induced mitochondrial dysfunction: a narrative review. World J Crit Care Med. 2023;12:139\u201352.","journal-title":"World J Crit Care Med"},{"key":"982_CR27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49920","author":"AM Owen","year":"2019","unstructured":"Owen AM, et al. Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model. Elife. 2019. https:\/\/doi.org\/10.7554\/eLife.49920.","journal-title":"Elife"},{"key":"982_CR28","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17376.1","author":"S Piva","year":"2019","unstructured":"Piva S, Fagoni N, Latronico N. Intensive care unit-acquired weakness: unanswered questions and targets for future research. F1000Research. 2019. https:\/\/doi.org\/10.12688\/f1000research.17376.1.","journal-title":"F1000Research"},{"key":"982_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13613-021-00970-x","volume":"11","author":"S Preau","year":"2021","unstructured":"Preau S, et al. Correction to: energetic dysfunction in sepsis: a narrative review. Ann Intensive Care. 2021;11:185.","journal-title":"Ann Intensive Care"},{"key":"982_CR30","doi-asserted-by":"publisher","first-page":"W193","DOI":"10.1093\/nar\/gkm226","volume":"35","author":"J Reimand","year":"2007","unstructured":"Reimand J, Kull M, Peterson H, Hansen J, Vilo J. g:Profiler\u2014a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 2007;35:W193\u2013200.","journal-title":"Nucleic Acids Res"},{"key":"982_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395:200\u201311.","journal-title":"Lancet"},{"key":"982_CR32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1164\/rccm.201512-2344OC","volume":"194","author":"C Dos Santos","year":"2016","unstructured":"Dos Santos C, et al. Mechanisms of chronic muscle wasting and dysfunction after an intensive care unit stay. a Pilot Study. Am J Respir Crit Care Med. 2016;194:821\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"982_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13539-010-0010-6","volume":"1","author":"JC Schefold","year":"2010","unstructured":"Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 2010;1:147\u201357.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"982_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/viru.26907","volume":"5","author":"M Singer","year":"2014","unstructured":"Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014;5:66\u201372.","journal-title":"Virulence"},{"key":"982_CR35","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.2147\/IDR.S390947","volume":"16","author":"EC van der Slikke","year":"2023","unstructured":"van der Slikke EC, et al. Understanding post-sepsis syndrome: how can clinicians help? Infect Drug Resist. 2023;16:6493\u2013511.","journal-title":"Infect Drug Resist"},{"key":"982_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115705","volume":"9","author":"ME Starr","year":"2014","unstructured":"Starr ME, et al. A new cecal slurry preparation protocol with improved long-term reproducibility for animal models of sepsis. PLoS ONE. 2014;9: e115705.","journal-title":"PLoS ONE"},{"key":"982_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/SHK.0000000000000799","volume":"47","author":"AM Steele","year":"2017","unstructured":"Steele AM, Starr ME, Saito H. Late therapeutic intervention with antibiotics and fluid resuscitation allows for a prolonged disease course with high survival in a severe murine model of sepsis. Shock. 2017;47:726\u201334.","journal-title":"Shock"},{"key":"982_CR38","doi-asserted-by":"publisher","first-page":"30116","DOI":"10.1074\/jbc.273.46.30116","volume":"273","author":"BE Sturgeon","year":"1998","unstructured":"Sturgeon BE, et al. The fate of the oxidizing tyrosyl radical in the presence of glutathione and ascorbate. Implications for the radical sink hypothesis. J Biol Chem. 1998;273:30116\u201321.","journal-title":"J Biol Chem"},{"key":"982_CR39","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/bph.12461","volume":"171","author":"HH Szeto","year":"2014","unstructured":"Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171:2029\u201350.","journal-title":"Br J Pharmacol"},{"key":"982_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12731","volume":"17","author":"S Tarantini","year":"2018","unstructured":"Tarantini S, et al. Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice. Aging Cell. 2018;17: e12731.","journal-title":"Aging Cell"},{"key":"982_CR41","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s001340000586","volume":"26","author":"A Tennila","year":"2000","unstructured":"Tennila A, et al. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 2000;26:1360\u20133.","journal-title":"Intensive Care Med"},{"key":"982_CR42","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/CCM.0000000000004897","volume":"49","author":"HE Wang","year":"2021","unstructured":"Wang HE, et al. Trajectory of cognitive decline after sepsis. Crit Care Med. 2021;49:1083\u201394.","journal-title":"Crit Care Med"},{"issue":"124","key":"982_CR43","first-page":"40","volume":"1985","author":"Y Wen","year":"2018","unstructured":"Wen Y, et al. MyoVision: software for automated high-content analysis of skeletal muscle immunohistochemistry. J Appl Physiol Bethesda Md. 2018;1985(124):40\u201351.","journal-title":"J Appl Physiol Bethesda Md"},{"key":"982_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13213","volume":"19","author":"JA Whitson","year":"2020","unstructured":"Whitson JA, et al. SS-31 and NMN: Two paths to improve metabolism and function in aged hearts. Aging Cell. 2020;19: e13213.","journal-title":"Aging Cell"},{"key":"982_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1378\/chest.99.1.176","volume":"99","author":"NJ Witt","year":"1991","unstructured":"Witt NJ, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest. 1991;99:176\u201384.","journal-title":"Chest"},{"key":"982_CR46","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1172\/JCI118909","volume":"98","author":"HC Yen","year":"1996","unstructured":"Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest. 1996;98:1253\u201360.","journal-title":"J Clin Invest"},{"key":"982_CR47","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.3390\/ijms24055040","volume":"24","author":"I Yoshihara","year":"2023","unstructured":"Yoshihara I, Kondo Y, Okamoto K, Tanaka H. Sepsis-associated muscle wasting: a comprehensive review from bench to bedside. Int J Mol Sci. 2023;24:5040.","journal-title":"Int J Mol Sci"},{"key":"982_CR48","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.bcp.2005.08.022","volume":"70","author":"K Zhao","year":"2005","unstructured":"Zhao K, Luo G, Giannelli S, Szeto HH. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem Pharmacol. 2005;70:1796\u2013806.","journal-title":"Biochem Pharmacol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-00982-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-024-00982-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-00982-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:04:28Z","timestamp":1732061068000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-00982-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1186\/s10020-024-00982-w","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted according to procedures described in our Animal Use Protocol #2009-0541 which is approved by the Institutional Animal Care and Use Committee at the University of Kentucky.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}